{"title": "PDF", "author": "PDF", "url": "https://www.sabin.org/app/uploads/2022/07/Nathalia-Katz.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "54, 61, 70, 72, 81 y CP6108 VPH de alto riesgo : 16, 18 , 31, 33, 35, 39, 45, 51, 52, 56, 58 y 59 Prevalencia de VPH 16 y 18 en CC en Am Lat* 66,4% *Ciapponi y col. Type -Specific HPV Prevalence in Cervical Cancer and High -Grade Lesions in Latin America and the Caribbean: Systematic Review and Meta - usa la CIN 2 CIN 3 ADN viral episomalHSIL 10 a 15 2.Efficacy of human Vaccin de otros c\u00e1nceres 1. The FUTURE II Study Group. N Engl J Med 2007, 356;19 2. Kjear SK y col. Cancer Prev Res 2009; -878. Herrero R y col. One. 2013;8:e68329. 4. Giuliano A y col. N Med -11. otros canceres relacionados JID 2009:199 (1 April) Brown et al. Wheeler. base a datos con VIH 18 a a\u00f1os 22 a (93%) 25 a 35 a\u00f1os 11 1% Dis. Cummings (EEUU) Schlecht et al. PloS One 2012 (EEUU) Powell et al. Vaccine 2012 (EEUU) Deler\u00e9 et BMC ) Tabrizi et al . Lancet Infect Dis 2014 (Australia) Chow et al. Lancet Infect Dis 2015 (Australia) Markowitz et al. Pediatrics 2016 (EEUU)Impacto sobre infecci\u00f3n por VPH Kahn et al. Pediatrics 2012 (EEUU) Markowitz et al. . J Infect Dis Cancer Prev 2014( B\u00e9lgica ) Wilson et al. Online J Public Health Inform 2014 (EEUU) Dickson et al. Epidemiol Infect 2015 Garland y Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real -world Experience. CID. 2016 Aug 15;63(4):519 -27 Prevalencia de PRIMER HACIA LA VIGILANCIA EN LA de La Banda y Santiago del Estero ) ; E Berner , V Cramer, P Real (Hospital Argerich , CABA ); C Lopez al. BMJ. 2013;346:f2032. Pacientes (%)20 16 12 8 4 0 2004 2005 2006 2007 2008 2009 2010 2011 Pre-vacunaci\u00f3n Post-vacunaci\u00f3nPtrend <0.001Ptrend<0.001-72.6% -92.6%Introducci\u00f3n VPH4 Post-vacunaci\u00f3n20 16 12 8 4 0 2004 2005 2006 2007 2008 2009 2004 -2011 Impacto en VG Donovan et al. (Australia) Leval et al JNCI 2012 ( Suecia ) Bauer et al Am J Pub Health Mikolajczyk et al. STD Chow et al STI 2014 (Australia) Dominiak G et al. PloS One 2015 ( Smith et al Pediatrics al BMC 2016 (Australia)Efecto reba\u00f1o Sin impacto HSHDrolet y col. Dis. May ; 15(5): 565 -580. Impacto de 1.60 1.20 0.80 0.40 0 2003 2004 2005 2006 de ACAG(%) -Queensland -Australia Garland y Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real -world Experience. CID. 2016 Aug 15;63(4):519 -27Esquemas completos de la vacunaci\u00f3n -Suecia Garland y col. Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real -world Experience. CID. 2016 Aug 15;63(4):519 -27CReducci\u00f3n "}